Cargando…

Serum neutralizing capacity and T-cell response against the omicron BA.1 variant in seropositive children and their parents one year after SARS-CoV-2 infection

INTRODUCTION: Durability of immune protection against reinfection with SARS-CoV-2 remains enigmatic, especially in the pediatric population and in the context of immune-evading variants of concern. Obviously, this knowledge is required for measures to contain the spread of infection and in selecting...

Descripción completa

Detalles Bibliográficos
Autores principales: Seidel, Alina, Jacobsen, Eva-Maria, Fabricius, Dorit, Class, Magdalena, Zernickel, Maria, Blum, Carmen, Conzelmann, Carina, Weil, Tatjana, Groß, Rüdiger, Bode, Sebastian F. N., Renk, Hanna, Elling, Roland, Stich, Maximillian, Kirchhoff, Frank, Debatin, Klaus-Michael, Münch, Jan, Janda, Aleš
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10083310/
https://www.ncbi.nlm.nih.gov/pubmed/37051428
http://dx.doi.org/10.3389/fped.2023.1020865
_version_ 1785021480910716928
author Seidel, Alina
Jacobsen, Eva-Maria
Fabricius, Dorit
Class, Magdalena
Zernickel, Maria
Blum, Carmen
Conzelmann, Carina
Weil, Tatjana
Groß, Rüdiger
Bode, Sebastian F. N.
Renk, Hanna
Elling, Roland
Stich, Maximillian
Kirchhoff, Frank
Debatin, Klaus-Michael
Münch, Jan
Janda, Aleš
author_facet Seidel, Alina
Jacobsen, Eva-Maria
Fabricius, Dorit
Class, Magdalena
Zernickel, Maria
Blum, Carmen
Conzelmann, Carina
Weil, Tatjana
Groß, Rüdiger
Bode, Sebastian F. N.
Renk, Hanna
Elling, Roland
Stich, Maximillian
Kirchhoff, Frank
Debatin, Klaus-Michael
Münch, Jan
Janda, Aleš
author_sort Seidel, Alina
collection PubMed
description INTRODUCTION: Durability of immune protection against reinfection with SARS-CoV-2 remains enigmatic, especially in the pediatric population and in the context of immune-evading variants of concern. Obviously, this knowledge is required for measures to contain the spread of infection and in selecting rational preventive measures. METHODS: Here, we investigated the serum neutralization capacity of 36 seropositive adults and 34 children approximately one year after infection with the ancestral Wuhan strain of SARS-CoV-2 by using a pseudovirus neutralization assay. RESULTS: We found that 88.9% of seropositive adult (32/36) and 94.1% of seropositive children (32/34) convalescents retained the neutralizing activity against the SARS-CoV-2 Wuhan strain (WT). Although, the neutralization effect against Omicron BA.1 (B.1.1.529.1) was significantly lower, 70.6% (24/34) of children and 41.7% (15/36) of adults possessed BA.1 cross-neutralizing antibodies. The spike 1 (S1)-specific T cell recall capacity using an activation-induced marker assay was analyzed in 18 adults and 16 children. All participants had detectable S1-specific CD4 T cells against WT, and 72.2% (13/18) adults and 81,3% (13/16) children had detectable S1 WT-specific CD8 T cells. CD4 cross-reactivity against BA.1 was demonstrated in all investigated adults (18/18), and 66.7% (12/18) adult participants had also detectable specific CD8 BA.1 T cells while we detected BA.1 S1 reactive CD4 and CD8 T cells in 81.3% (13/16) children. DISCUSSION: Together, our findings demonstrate that infection with the ancestral strain of SARS-CoV-2 in children as well as in adults induces robust serological as well as T cell memory responses that persist over at least 12 months. This suggests persistent immunological memory and partial cross-reactivity against Omicron BA.1.
format Online
Article
Text
id pubmed-10083310
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-100833102023-04-11 Serum neutralizing capacity and T-cell response against the omicron BA.1 variant in seropositive children and their parents one year after SARS-CoV-2 infection Seidel, Alina Jacobsen, Eva-Maria Fabricius, Dorit Class, Magdalena Zernickel, Maria Blum, Carmen Conzelmann, Carina Weil, Tatjana Groß, Rüdiger Bode, Sebastian F. N. Renk, Hanna Elling, Roland Stich, Maximillian Kirchhoff, Frank Debatin, Klaus-Michael Münch, Jan Janda, Aleš Front Pediatr Pediatrics INTRODUCTION: Durability of immune protection against reinfection with SARS-CoV-2 remains enigmatic, especially in the pediatric population and in the context of immune-evading variants of concern. Obviously, this knowledge is required for measures to contain the spread of infection and in selecting rational preventive measures. METHODS: Here, we investigated the serum neutralization capacity of 36 seropositive adults and 34 children approximately one year after infection with the ancestral Wuhan strain of SARS-CoV-2 by using a pseudovirus neutralization assay. RESULTS: We found that 88.9% of seropositive adult (32/36) and 94.1% of seropositive children (32/34) convalescents retained the neutralizing activity against the SARS-CoV-2 Wuhan strain (WT). Although, the neutralization effect against Omicron BA.1 (B.1.1.529.1) was significantly lower, 70.6% (24/34) of children and 41.7% (15/36) of adults possessed BA.1 cross-neutralizing antibodies. The spike 1 (S1)-specific T cell recall capacity using an activation-induced marker assay was analyzed in 18 adults and 16 children. All participants had detectable S1-specific CD4 T cells against WT, and 72.2% (13/18) adults and 81,3% (13/16) children had detectable S1 WT-specific CD8 T cells. CD4 cross-reactivity against BA.1 was demonstrated in all investigated adults (18/18), and 66.7% (12/18) adult participants had also detectable specific CD8 BA.1 T cells while we detected BA.1 S1 reactive CD4 and CD8 T cells in 81.3% (13/16) children. DISCUSSION: Together, our findings demonstrate that infection with the ancestral strain of SARS-CoV-2 in children as well as in adults induces robust serological as well as T cell memory responses that persist over at least 12 months. This suggests persistent immunological memory and partial cross-reactivity against Omicron BA.1. Frontiers Media S.A. 2023-03-27 /pmc/articles/PMC10083310/ /pubmed/37051428 http://dx.doi.org/10.3389/fped.2023.1020865 Text en © 2023 Seidel, Jacobsen, Fabricius, Class, Zernickel, Blum, Conzelmann, Weil, Groß, Bode, Renk, Elling, Stich, Kirchhoff, Debatin, Müench and Janda. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY) (https://creativecommons.org/licenses/by/4.0/) . The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Pediatrics
Seidel, Alina
Jacobsen, Eva-Maria
Fabricius, Dorit
Class, Magdalena
Zernickel, Maria
Blum, Carmen
Conzelmann, Carina
Weil, Tatjana
Groß, Rüdiger
Bode, Sebastian F. N.
Renk, Hanna
Elling, Roland
Stich, Maximillian
Kirchhoff, Frank
Debatin, Klaus-Michael
Münch, Jan
Janda, Aleš
Serum neutralizing capacity and T-cell response against the omicron BA.1 variant in seropositive children and their parents one year after SARS-CoV-2 infection
title Serum neutralizing capacity and T-cell response against the omicron BA.1 variant in seropositive children and their parents one year after SARS-CoV-2 infection
title_full Serum neutralizing capacity and T-cell response against the omicron BA.1 variant in seropositive children and their parents one year after SARS-CoV-2 infection
title_fullStr Serum neutralizing capacity and T-cell response against the omicron BA.1 variant in seropositive children and their parents one year after SARS-CoV-2 infection
title_full_unstemmed Serum neutralizing capacity and T-cell response against the omicron BA.1 variant in seropositive children and their parents one year after SARS-CoV-2 infection
title_short Serum neutralizing capacity and T-cell response against the omicron BA.1 variant in seropositive children and their parents one year after SARS-CoV-2 infection
title_sort serum neutralizing capacity and t-cell response against the omicron ba.1 variant in seropositive children and their parents one year after sars-cov-2 infection
topic Pediatrics
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10083310/
https://www.ncbi.nlm.nih.gov/pubmed/37051428
http://dx.doi.org/10.3389/fped.2023.1020865
work_keys_str_mv AT seidelalina serumneutralizingcapacityandtcellresponseagainsttheomicronba1variantinseropositivechildrenandtheirparentsoneyearaftersarscov2infection
AT jacobsenevamaria serumneutralizingcapacityandtcellresponseagainsttheomicronba1variantinseropositivechildrenandtheirparentsoneyearaftersarscov2infection
AT fabriciusdorit serumneutralizingcapacityandtcellresponseagainsttheomicronba1variantinseropositivechildrenandtheirparentsoneyearaftersarscov2infection
AT classmagdalena serumneutralizingcapacityandtcellresponseagainsttheomicronba1variantinseropositivechildrenandtheirparentsoneyearaftersarscov2infection
AT zernickelmaria serumneutralizingcapacityandtcellresponseagainsttheomicronba1variantinseropositivechildrenandtheirparentsoneyearaftersarscov2infection
AT blumcarmen serumneutralizingcapacityandtcellresponseagainsttheomicronba1variantinseropositivechildrenandtheirparentsoneyearaftersarscov2infection
AT conzelmanncarina serumneutralizingcapacityandtcellresponseagainsttheomicronba1variantinseropositivechildrenandtheirparentsoneyearaftersarscov2infection
AT weiltatjana serumneutralizingcapacityandtcellresponseagainsttheomicronba1variantinseropositivechildrenandtheirparentsoneyearaftersarscov2infection
AT großrudiger serumneutralizingcapacityandtcellresponseagainsttheomicronba1variantinseropositivechildrenandtheirparentsoneyearaftersarscov2infection
AT bodesebastianfn serumneutralizingcapacityandtcellresponseagainsttheomicronba1variantinseropositivechildrenandtheirparentsoneyearaftersarscov2infection
AT renkhanna serumneutralizingcapacityandtcellresponseagainsttheomicronba1variantinseropositivechildrenandtheirparentsoneyearaftersarscov2infection
AT ellingroland serumneutralizingcapacityandtcellresponseagainsttheomicronba1variantinseropositivechildrenandtheirparentsoneyearaftersarscov2infection
AT stichmaximillian serumneutralizingcapacityandtcellresponseagainsttheomicronba1variantinseropositivechildrenandtheirparentsoneyearaftersarscov2infection
AT kirchhofffrank serumneutralizingcapacityandtcellresponseagainsttheomicronba1variantinseropositivechildrenandtheirparentsoneyearaftersarscov2infection
AT debatinklausmichael serumneutralizingcapacityandtcellresponseagainsttheomicronba1variantinseropositivechildrenandtheirparentsoneyearaftersarscov2infection
AT munchjan serumneutralizingcapacityandtcellresponseagainsttheomicronba1variantinseropositivechildrenandtheirparentsoneyearaftersarscov2infection
AT jandaales serumneutralizingcapacityandtcellresponseagainsttheomicronba1variantinseropositivechildrenandtheirparentsoneyearaftersarscov2infection